Lozenges with probiotic strains enhance oral immune response and health

<jats:title>Abstract</jats:title>
<jats:sec>
<jats:title>Objective</jats:title>
<jats:p>Probiotics participate in regulating oral microbiota and reducing the prevalence of oral diseases; however, clinical research on probiotics is insufficient. Therefore, in this study, we performed in vitro screening of potential oral protective probiotic strains and then evaluated the clinical efficacy of the selected strains on maintaining oral health.</jats:p>
</jats:sec>
<jats:sec>
<jats:title>Materials and methods</jats:title>
<jats:p>
Fifty healthy individuals were recruited and randomly assigned into the placebo group and probiotics group, which included three strains of probiotics,
<jats:italic>Lactobacillus salivarius</jats:italic>
subs.
<jats:italic>salicinius</jats:italic>
AP‐32,
<jats:italic>Lactobacillus paracasei</jats:italic>
ET‐66, and
<jats:italic>Lactobacillus plantarum</jats:italic>
LPL28. Each group was blindly administered placebo or probiotics for four weeks.
</jats:p>
</jats:sec>
<jats:sec>
<jats:title>Results</jats:title>
<jats:p>
Next‐generation sequencing results showed that the oral microbiota of
<jats:italic>Lactobacillus salivarius</jats:italic>
in the oral cavity were significantly increased in subjects supplemented with mixed probiotic lozenges. The anti‐bacterial activities of viable probiotics were observed within two weeks. Both IgA levels and
<jats:italic>Lactobacillus</jats:italic>
and
<jats:italic>Bifidobacterium</jats:italic>
abundances in the oral cavity were significantly increased in the experimental groups, along with a reduced formation of plaque. Most participants reported that their oral health conditions and intestinal symptoms had improved.
</jats:p>
</jats:sec>
<jats:sec>
<jats:title>Conclusions</jats:title>
<jats:p>Overall, our clinical study suggests that oral probiotic lozenges may enhance oral immunity, modulate oral microbiota, and improve oral health.</jats:p>
</jats:sec>